The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index; 201 of the 294 sources its claims cite were checked for support.
Current update on malaria in pregnancy: a systematic review
Open accessAbstract
BACKGROUND: Malaria during pregnancy poses significant risks to both the mother and the developing fetus. For pregnant women, the infection can result in severe illness and even death. Parasite sequestration in the placenta can cause maternal anemia and increase the risk of mortality both during and after childbirth. Malaria is also a major contributor to stillbirths and preterm births. Infected placental tissue can impede fetal growth, resulting in low birth weight, which is linked to delayed growth and cognitive development in the child. Furthermore, malaria during pregnancy remains a major contributor to perinatal, neonatal, and infant mortality. OBJECTIVES: To review the epidemiological patterns of malaria in pregnancy and its impact on maternal and neonatal health, and to analyze the availability and effectiveness of drug treatment options. METHODS: Relevant articles published only in English were searched using electronic databases such as PubMed, Web of Science, Scopus, and Pro-Quest. Keywords including "'malaria in pregnancy", "placental malaria", "congenital malaria", "treatment options", and "nutrition intervention and intermittent preventive treatment" were used in combination. Of the total of 4,486 articles identified, 139 articles were ultimately included. Whereas, others were excluded due to duplication, irrelevant abstract, title, and quality assessment. RESULTS: From 139 included studies, 47 focused on epidemiology of malaria in pregnancy, 58 on its impact and 16 on treatment options and 18 on nutrition intervention and intermittent treatment. Plasmodium falciparum is the leading cause of complications in pregnant women and is primarily found in Africa, while P.vivax is recognized as an emerging global threat, and causing serious consequences. Other species, such as P.knowlesi, P.ovale, and P.malariae are less common. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases. The disease causes serious complications such as maternal anemia, premature birth, and low birth weight, severe anemia and increased maternal and infant mortality. Prevention strategies like intermittent preventive treatment (IPTp), insecticide-treated nets (ITNs) and Indoor residual spray (IRS) are essential. Early diagnosis and treatment can reverse adverse effects on placental and congenital function. Artesunate is recommended for severe malaria in all trimesters. Even resistance to chloroquine reported in some areas, it is the drug of choice for uncomplicated P.vivax infections. CONCLUSIONS: Malaria during pregnancy significantly impacts maternal and fetal health, leading to anemia, growth restriction, preterm birth, and neonatal death. Infants born to mothers with malaria are more likely to contract the disease. Further research and improved treatment strategies are needed to address this issue effectively.
Overview
CoChat Summary
TL;DR
This systematic review synthesizes 139 studies on malaria in pregnancy, covering epidemiology, maternal and neonatal impacts, treatment, and prevention. It reports that *P. falciparum* drives severe complications mainly in Africa while *P. vivax* is an emerging global threat, and that artesunate, IPTp-SP, ITNs, IRS, and nutritional supplementation are central management strategies.
Key findings
- From 139 included studies, 47 addressed epidemiology, 58 addressed impact, 16 addressed treatment options, and 18 addressed nutrition intervention and intermittent preventive treatment. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases.
- *P. falciparum* is the leading cause of complications in pregnant women and is primarily found in Africa; *P. vivax* is recognized as an emerging global threat. Other species, such as *P. knowlesi*, *P. ovale*, and *P. malariae*, are less common.
- Adverse outcomes include maternal anemia, premature birth, low birth weight, severe anemia, and increased maternal and infant mortality. Congenital malaria prevalence varied, for example Niger recorded 26.5% for *P. falciparum*, Uganda 6.1%, and Sudan 18.6–56.8% by PCR of cord blood samples.
- Artesunate is recommended for severe malaria in all trimesters; chloroquine remains the drug of choice for uncomplicated *P. vivax* in some areas despite reported resistance. IPTp-SP with three or more doses reduced the risk of low birth weight by 56% compared with fewer than three doses in HIV-negative women.
Methods
- PRISMA-based systematic review; searched PubMed, Web of Science, Scopus, and Pro-Quest using MeSH terms and text words including “malaria in pregnancy,” “placental malaria,” “congenital malaria,” “treatment options,” “nutrition interventions,” and “intermittent preventive treatment,” with filters English, Humans, female, from 2000/1/1 to 2024/12/12.
- Two authors independently extracted data using a standardized JBI-modified form; two authors independently assessed quality with a nine-criterion JBI checklist adapted for prevalence studies. Studies scoring above 50% were included, while those scoring 50% or below were excluded.
- The abstract reports 4,486 articles identified and 139 ultimately included; the results section reports an initial search yielding 4,269 publications, with 1,027 duplicates removed, 2,211 excluded on title/abstract, 892 removed after further screening, leaving 139 articles.
Limitations
- Stated: only articles published exclusively in English peer-reviewed, open-access journals were included, potentially excluding relevant studies from non-peer-reviewed sources or grey literature. Exclusion of articles without full-text access, focusing on non-pregnant populations or non-malaria conditions, or lacking sufficient data may have omitted valuable data. These inclusion and exclusion criteria may have led to selection bias, limiting generalizability.
- Evident: the abstract and results report different initial article counts (4,486 vs. 4,269), and the review presents a narrative/tabular synthesis without a meta-analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
105 Valid · 18 Not valid · 47 Not checked · 69 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Currently, RTS, S/AS01 (RTS, S) is the only malaria vaccine specifically recommended for use in pregnant women.”
§ Current update on malaria in pregnancy: a systematic review > Discussion
What the sources say
- Disputedcites [218] Mumtaz H, Nadeem A, Bilal W, Ansar F, Saleem S, Khan QA, et al. Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: a review. Immun Inflam Dis. 2023;11(6):e899. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) describes the WHO-recommended RTS,S/AS01 regimen as beginning at about five months of age, with the third dose completed by nine months. The “Mode of administration, dosage, and side effects” section likewise describes it as a childhood vaccine. The source thus describes a recommendation for children, not one specifically for pregnant women. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Disputedcites [219] Ogieuhi IJ, Ajekiigbe VO, Kolo-Manma K, Akingbola A, Odeniyi TA, Soyemi TS, et al. A narrative review of the RTS S AS01 malaria vaccine and its implementation in Africa to reduce the global malaria burden. Discover Public Health. 2024;21(1):1–13. sourceExperimental — accuracy not yet measured
Section 1.1, “RTS, S/AS01 vaccine: an overview” (page not provided), says WHO recommends four doses for children, beginning at five months of age. It does not describe a recommendation for pregnant women; the population it identifies is contrary to the claim. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Several studies have confirmed that infections with P.knowlesi, P.malariae and P.ovale in pregnant women can lead to adverse maternal and pregnancy outcomes.”
§ Current update on malaria in pregnancy: a systematic review > Result > Effects of malaria during pregnancy
What the sources say
- Not checked — no full text of the sourcecites [25] Barber BE, Bird E, Wilkes CS, William T, Grigg MJ, Paramaswaran U, et al. Plasmodium knowlesi malaria during pregnancy. J Infect Dis. 2015;211(7):1104–10. source
- Disputedcites [27] Doritchamou JY, Akuffo RA, Moussiliou A, Luty AJ, Massougbodji A, Deloron P, et al. Submicroscopic placental infection by non-falciparum Plasmodium spp. PLoS Negl Trop Dis. 2018;12(2):e0006279. sourceExperimental — accuracy not yet measured
The Abstract’s Conclusions state that the study found no association between non-falciparum infections and adverse pregnancy outcomes. The Results likewise report no relationship with low birth weight or maternal anemia at delivery; the study detected P. malariae and P. ovale but does not report outcome findings for P. knowlesi. It therefore does not confirm the attributed claim. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Accordingly, Lopez-Perez et al. (2018) conducted a study in Colombia and found that men and children often have high levels of functional VAR2CSA-specific IgG.”
§ Current update on malaria in pregnancy: a systematic review > Result > Effects of malaria during pregnancy
What the sources say
- Disputedcites Lopez-Perez et al. (2018) sourceExperimental — accuracy not yet measured
The Results (page not provided) found frequent IgG reactivity in Colombian men and children to an insect-cell-produced recombinant protein, but only 7% of their samples had IgG to its native counterpart above the cutoff. The Discussion (page not provided) cautions that recombinant-protein reactivity need not reflect recognition of native VAR2CSA. The paper therefore does not find that men and children often have high levels of functional VAR2CSA-specific IgG; it argues against that interpretation. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A study by Barnadas et al. (2007) found that sulfadoxine-pyrimethamine (SP) is effective as monotherapy, for intermittent preventive treatment of pregnant women or children [144] (Additional file 5:Table S5).”
§ Current update on malaria in pregnancy: a systematic review > Result > Antimalarial treatment for malaria during pregnancy
What the sources say
- Not matchedcites Barnadas et al. (2007)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Disputedcites [144] Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, et al. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar J. 2008;7:1–11. sourceExperimental — accuracy not yet measured
The Conclusion says SP will not be completely effective for intermittent preventive treatment during pregnancy in Madagascar and raises concern about using it as monotherapy for pregnant women or children. The Results report a 19% treatment-failure rate after adjustment by genotyping; the study does not find the claimed effectiveness for preventive treatment. (LLM, conf=0.92)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Although P.falciparum and P.vivax infections during pregnancy have been extensively studied, non-falciparum infections in women infected with these parasites also have a significant impact on pregnancy outcomes [27, 68].”
§ Current update on malaria in pregnancy: a systematic review > Discussion
What the sources say
- Partly supportedcites [27] Doritchamou JY, Akuffo RA, Moussiliou A, Luty AJ, Massougbodji A, Deloron P, et al. Submicroscopic placental infection by non-falciparum Plasmodium spp. PLoS Negl Trop Dis. 2018;12(2):e0006279. sourceExperimental — accuracy not yet measured
The Results section reports that mixed infections at enrolment were significantly associated with premature delivery (p = 0.037), supporting an effect on one pregnancy outcome. But non-falciparum infections alone were not significantly associated with prematurity, low birth weight, or maternal anaemia; the claim overstates the evidence for non-falciparum infections generally. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Disputedcites [68] Williams J, Njie F, Cairns M, Bojang K, Coulibaly SO, Kayentao K, et al. Non-falciparum malaria infections in pregnant women in West Africa. Malar J. 2016;15:53. sourceExperimental — accuracy not yet measured
The Discussion reports no association between non-falciparum infection at first antenatal visit and adverse pregnancy outcomes. The Abstract Conclusions say these infections were unlikely to have had an important impact on pregnancy outcomes in the communities studied, while noting that few women were infected. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
102 more claims · 45 with their cited sources checked
Create a free account to see all 239 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 98
- Probably not a substantial claim. 53
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Current update on malaria in pregnancy: a systematic review > Conclusion
“Artesunate is the drug of choice for all forms of malaria at any stage of pregnancy.”
§ Current update on malaria in pregnancy: a systematic review > Conclusion
“ACTs, such as artemether-lumefantrine (AL, Coartem), are the preferred treatment for uncomplicated P.falciparum cases at all stages of pregnancy.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Current update on malaria in pregnancy: a systematic review > Result > Epidemiology of malaria in pregnancy: a global perspective
“In general, the data indicate a decline in malaria in pregnancy over time, reflecting the impact of improved prevention measures and treatment strategies.”
§ Current update on malaria in pregnancy: a systematic review > Result > Epidemiology of malaria in pregnancy: a global perspective
“From 2000 to 2023, the global trend shows an overall increase in the prevalence and burden of malaria in pregnancy but decline in estimation of malaria in pregnancy cases, due to interventions such as IPTp, ITNs, and better treatment protocols.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Current update on malaria in pregnancy: a systematic review > Result > Congenital malaria
“Sudan exhibited a wide range of prevalence, with figures between 18.6% and 56.8% determined through PCR analyses of cord blood samples.”
§ Current update on malaria in pregnancy: a systematic review > Result > Epidemiology of malaria in pregnancy: a global perspective
“| Omer et al.(2020) | Sudan | *56.8 | NA | 0 | NA | 0 | NA | [41] |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Mean | India | 19.5 | NA | 13.6 | - | 4.6 | NA | |”
§ Current update on malaria in pregnancy: a systematic review > Result > Epidemiology of malaria in pregnancy: a global perspective
Reported 19.5 · recomputed 17.983333
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Mean | Colombia | 0.82 | 0.82 | 8.2 | 2.3 | 2.3 | 5.1 | 0 | 0.8 | |”
§ Current update on malaria in pregnancy: a systematic review > Result > Epidemiology of malaria in pregnancy: a global perspective
Reported 2.3 · recomputed 1.4
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Every Newborn: progress, priorities, and potential beyond survival
Lawn, J. E., Blencowe, H., Oza, S., You, D., Lee, A. C., Waiswa, P., Lalli, M., Bhutta, Z., Barros, A. J., Christian, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60496-7 · Cited by 1,929
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628 · cited 2×
“Asymptomatic infections show no obvious symptoms but can still pose a significant risk to fetal development [15].”
The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome
Miller, S. L., Huppi, P. S., & Mallard, C. (2016) · The Journal of Physiology · doi:10.1113/jp271402 · Cited by 620
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact
Malhotra, A., Allison, B. J., Castillo-Melendez, M., Jenkin, G., Polglase, G. R., & Miller, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00055 · Cited by 453
Murphy, S., & Breman, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.57 · Cited by 451
Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Research works printed but not linked: 25
- Obeagu E, Obeagu G. Neonatal outcomes in children born to mothers with severe Malaria, HIV, and transfusion history: a review. Elite J Nurs Health Sci. 2024;2(3):38–58.
- Bôtto-Menezes C, Bardají A, Campos GDS, Fernandes S, Hanson K, Martínez-Espinosa FE, et al. Costs associated with malaria in pregnancy in the brazilian amazon, a low endemic area where Plasmodium vivax predominates. PLoS Negl Trop Dis. 2016;10(3):e0004494. · DOI
- Dombrowski JGR, Souza RMD, Regina NR, Silva M, Barateiro A, Epiphanio S, et al. Malaria during pregnancy and newborn outcome in an unstable transmission area in Brazil: a population-based record linkage study. PLoS ONE. 2018;13(6):e0199415. · DOI · Paper page
- Agudelo O, Arango E, Maestre A, Carmona-Fonseca J. Prevalence of gestational, placental and congenital malaria in north-west Colombia. Malar J. 2013;12:341. · DOI
- Khan WA, Galagan SR, Prue CS, Khyang J, Ahmed S, Ram M, et al. Asymptomatic Plasmodium falciparum Malaria in Pregnant Women in the Chittagong Hill Districts of Bangladesh. PLoS ONE. 2014;9(5):e9844. · DOI · Paper page
- Briand V, Hesran JYL, Mayxay M, Newton PN, Bertin G, Houzé S, et al. Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malar J. 2016;15:436. · DOI
- Williams J, Njie F, Cairns M, Bojang K, Coulibaly SO, Kayentao K, et al. Non-falciparum malaria infections in pregnant women in West Africa. Malar J. 2016;15:53. · DOI · Paper page
- Unger HW, Rosanas-Urgell A, Robinson LJ, Ome-Kaius M, Jally S, Umbers AJ, et al. Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study. Malarria J. 2019;18:302. · DOI · Paper page
- Gontie GB, Wolde HF, Baraki AG. Prevalence and associated factors of malaria among pregnant women in Sherkole district, Benishangul Gumuz regional state West Ethiopia BMC. Infect Dis. 2020;20:573.
- Feleke DG, Adamu A, Gebreweld A, Tesfaye M, Demisiss W, Molla G. Asymptomatic malaria infection among pregnant women attending antenatal care in malaria endemic areas of North-Shoa, Ethiopia: a cross-sectional study. Malar J. 2020;19:67. · DOI
- Solomon A, Kahase D, Alemayhu M. Prevalence of placental malaria among asymptomatic pregnant women in Wolkite health center, Gurage zone, Southern Ethiopia. Trop Dis Travel Med Vacc. 2020;6:20. · DOI
- Limenih A, Gelaye W, Alemu G. Prevalence of Malaria and associated factors among delivering mothers in Northwest Ethiopia. Hindawi BioMed Res Int. 2021;2021:7.
- Gemechu T, Dedecha W, Gelchu M, Husen O, Jarso H. Asymptomatic Malaria during pregnancy: prevalence, influence on anemia and associated factors in West Guji Zone, Ethiopia – a community-based study. Infect Drug Resist. 2023;16:6747–55. · DOI
- Carmona-Fonseca J, Eliana A, Maestre A. Placental Malaria in Colombia: histopathologic findings in plasmodium vivax and P. falciparum infections. Am J Trop Med Hyg. 2013;88(6):1093–101. · DOI · Paper page
- Poespoprodjo ER, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, et al. Adverse pregnancy outcomes in an area where multidrug resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008;46(9):1374–81. · DOI · Paper page
- Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet Glob Health. 1999;354:546–9.
- Hegde A. Malaria in the intensive care Unit. Indian J Crit Care Med. 2021. https://doi.org/10.5005/jp-journals:10071-23871. · doi:10.5005/jp-journals:10071-23871
- Dombrowski JGR, Barateiro A, Peixoto EPM, Barros ABCudS, Souza MD, Clark TG, et al. Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon. PLoS Negl Trop Dis. 2021;15(4):e0009390. · DOI · Paper page
- Dobaño C, Bardajı´ A, Are´valo-Herrera M, Espinosa FEMn, Boˆtto-Menezes C, Padilla N, et al. Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes. PLoS Neglected Trop Dis 2020;14(5):e0008155. · DOI · Paper page
- Requena P, Rui E, Padilla N, MartõÂnez-Espinosa FE, Castellanos ME, tto-Menezes CB, et al. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. PLoS Neglected Tropical Diseases. 2016;10(10):e0005009. · DOI · Paper page
- Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, et al. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar J. 2008;7:1–11. · DOI · Paper page
- Dellicour S, Tatem AJ, Guerra CA, Snow RW, Kuile FOT. Quantifying the number of pregnancies at risk of Malaria in 2007: a demographic study. PLoS Med. 2010;7(1):e1000221. · DOI · Paper page
- Dellicour S, Tatem AJ, Guerra CA, Snow RW, Kuile FOT. Quantifying the number of pregnancies at risk of Malaria in 2007: a demographic study. PLoS Med. 2007;7(1):e1000221. · DOI · Paper page
- Reddy V, Weiss DJ, Rozier J, Kuile FOT, Dellicou S. Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. Lancet Glob Health. 2023;11:e40-7. · DOI · Paper page
- Laochan N, Zaloumis SG, Imwong M, Lek-Uthai U, Brockman A, Sriprawat K, et al. Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Malar J. 2015;14:1–9. · DOI
Cited by
Sargsyan, T. H., Stepanyan, L., Tsaturyan, A., Palumbo, R., Vicidomini, C., & Roviello, G. N. (2025) · Vaccines · doi:10.3390/vaccines13111082 · Cited by 11
Scott, R. K., Nachman, S., Weld, E. D., Daley, R., Atoyebi, S., Bies, R. R., Waitt, C. J., & Olagunju, A. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70224 · Cited by 7
Sex in Immune Cells and Parasitic Diseases — A Complex Relationship
Honecker, B., Hansen, C. S., & Lotter, H. (2026) · Immunological Reviews · doi:10.1111/imr.70097 · Cited by 8
Lawal, O. P., Stephen, J., David, V. O., Ajayi, T. C., Okunola, P., Atiku, N., Sone, P. E., Motilewa, O. O., Panwal, N. E., & Emenekwe, O. U. (2025) · Epidemiology and Health Data Insights · doi:10.63946/ehdi/16655 · Cited by 5
Burden and determinants of diabetes in sub-Saharan Africa
Agyemang, C. O., Tetteh, J., Mbaye, M. N., Lamptey, R., Seidu, S., Khunti, K., & Kengne, A. P. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00065-3 · Cited by 8
Metadata
- Authors
- Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G.
- Affiliations
- Debre Markos University (ET)
- Jimma University (ET)
- Corresponding author
- Minwuyelet, Awoke
- Venue
- Tropical Diseases, Travel Medicine and Vaccines
- Published
- 2025-05-22
- Volume
- 11
- Issue
- 1
- Pages
- 14-14
- ISSN
- 2055-0936 (ISSN-L)
- PMC
- PMC12096600
- OpenAlex
- W4410553944
- Cited by
- 49
- References
- 186
- Citations by year
- 2026: 40 · 2025: 8
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Tropical Diseases Travel Medicine and Vaccines (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- malaria in pregnancy, placental malaria, congenital malaria, Plasmodium falciparum, Plasmodium vivax, anemia in pregnancy, low birth weight, preterm birth, stillbirth, neonatal mortality, intermittent preventive treatment, insecticide-treated nets, indoor residual spraying, artemisinin-based combination therapy, chloroquine resistance, malaria treatment, nutrition interventions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current update on malaria in pregnancy: a systematic review. https://app.cochat.ai/papers/10.1186/s40794-025-00248-1
- The paper
- Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025). Current update on malaria in pregnancy: a systematic review. Tropical Diseases, Travel Medicine and Vaccines. https://doi.org/10.1186/s40794-025-00248-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.